| Robert Abel Jr, MD | |
|
3501 Silverside Road, Wilmington, DE 19810-4910 | |
| (302) 479-3937 | |
| (302) 477-2650 |
| Full Name | Robert Abel Jr |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 55 Years |
| Location | 3501 Silverside Road, Wilmington, Delaware |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1699719815 | NPI | - | NPPES |
| 171198 | Medicaid | NJ | |
| 0000054601 | Medicaid | DE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | CI0000715 (Delaware) | Secondary |
| 207W00000X | Ophthalmology | MA52946 (New Jersey) | Secondary |
| 207W00000X | Ophthalmology | C1-0000715 (Delaware) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Delaware Ophthalmology Consultants Pa | 0446247712 | 17 |
News Archive
In this post in the Center for Global Development's (CGD) "Global Health Policy" blog, Amanda Glassman, director of global health policy and a research fellow at the center, reports on the contribution of economists to the global health field, writing, "Economists are not global health's most popular human resource.
Asterias Biotherapeutics, Inc., a leading biotechnology company in the emerging field of regenerative medicine, announced today that Atlanta-based Shepherd Center, one of the nation's top rehabilitation hospitals for spinal cord injury and brain injury, has commenced enrollment for the Phase 1/2a clinical trial of AST-OPC1 (oligodendrocyte progenitor cells) in newly injured patients with sensory and motor complete cervical spinal cord injury (SCI).
From data gathered around the world experts predict that the deadliest type of malaria can be eradicated in 10 to 15 years. The disease affects half the global population and kills an estimated 1.2 million people worldwide every year. The organism responsible for deaths is commonly Plasmodium falciparum. The parasite is at its most deadly in sub-Saharan Africa, where 90 per cent of malaria fatalities occur.
Eighty years ago, the medical establishment believed cancer was caused by a dysfunction of metabolism, but the idea went out of vogue. Now, scientists are again looking at metabolism and its role in cancer and other common diseases. Metabolism is a highly connected network of reactions that are arranged in parallel and interacting pathways. Such parallelism can mask how genes are linked with disease traits and make it difficult to treat conditions.
Amylin Pharmaceuticals, Inc. and Eli Lilly and Company today announced results from the first double-blind, placebo-controlled clinical study to evaluate BYETTA (exenatide) injection added to Lantus (insulin glargine), which showed patients with type 2 diabetes achieved glucose targets without weight gain or increasing their risk of hypoglycemia. These findings were presented at the 70th Annual Scientific Sessions of the American Diabetes Association in Orlando, Fla.
› Verified 9 days ago
| Entity Name | Delaware Ophthalmology Consultants Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467496638 PECOS PAC ID: 0446247712 Enrollment ID: O20040428000967 |
News Archive
In this post in the Center for Global Development's (CGD) "Global Health Policy" blog, Amanda Glassman, director of global health policy and a research fellow at the center, reports on the contribution of economists to the global health field, writing, "Economists are not global health's most popular human resource.
Asterias Biotherapeutics, Inc., a leading biotechnology company in the emerging field of regenerative medicine, announced today that Atlanta-based Shepherd Center, one of the nation's top rehabilitation hospitals for spinal cord injury and brain injury, has commenced enrollment for the Phase 1/2a clinical trial of AST-OPC1 (oligodendrocyte progenitor cells) in newly injured patients with sensory and motor complete cervical spinal cord injury (SCI).
From data gathered around the world experts predict that the deadliest type of malaria can be eradicated in 10 to 15 years. The disease affects half the global population and kills an estimated 1.2 million people worldwide every year. The organism responsible for deaths is commonly Plasmodium falciparum. The parasite is at its most deadly in sub-Saharan Africa, where 90 per cent of malaria fatalities occur.
Eighty years ago, the medical establishment believed cancer was caused by a dysfunction of metabolism, but the idea went out of vogue. Now, scientists are again looking at metabolism and its role in cancer and other common diseases. Metabolism is a highly connected network of reactions that are arranged in parallel and interacting pathways. Such parallelism can mask how genes are linked with disease traits and make it difficult to treat conditions.
Amylin Pharmaceuticals, Inc. and Eli Lilly and Company today announced results from the first double-blind, placebo-controlled clinical study to evaluate BYETTA (exenatide) injection added to Lantus (insulin glargine), which showed patients with type 2 diabetes achieved glucose targets without weight gain or increasing their risk of hypoglycemia. These findings were presented at the 70th Annual Scientific Sessions of the American Diabetes Association in Orlando, Fla.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Robert Abel Jr, MD 3501 Silverside Road, Wilmington, DE 19810-4910 Ph: (302) 479-3937 | Robert Abel Jr, MD 3501 Silverside Road, Wilmington, DE 19810-4910 Ph: (302) 479-3937 |
News Archive
In this post in the Center for Global Development's (CGD) "Global Health Policy" blog, Amanda Glassman, director of global health policy and a research fellow at the center, reports on the contribution of economists to the global health field, writing, "Economists are not global health's most popular human resource.
Asterias Biotherapeutics, Inc., a leading biotechnology company in the emerging field of regenerative medicine, announced today that Atlanta-based Shepherd Center, one of the nation's top rehabilitation hospitals for spinal cord injury and brain injury, has commenced enrollment for the Phase 1/2a clinical trial of AST-OPC1 (oligodendrocyte progenitor cells) in newly injured patients with sensory and motor complete cervical spinal cord injury (SCI).
From data gathered around the world experts predict that the deadliest type of malaria can be eradicated in 10 to 15 years. The disease affects half the global population and kills an estimated 1.2 million people worldwide every year. The organism responsible for deaths is commonly Plasmodium falciparum. The parasite is at its most deadly in sub-Saharan Africa, where 90 per cent of malaria fatalities occur.
Eighty years ago, the medical establishment believed cancer was caused by a dysfunction of metabolism, but the idea went out of vogue. Now, scientists are again looking at metabolism and its role in cancer and other common diseases. Metabolism is a highly connected network of reactions that are arranged in parallel and interacting pathways. Such parallelism can mask how genes are linked with disease traits and make it difficult to treat conditions.
Amylin Pharmaceuticals, Inc. and Eli Lilly and Company today announced results from the first double-blind, placebo-controlled clinical study to evaluate BYETTA (exenatide) injection added to Lantus (insulin glargine), which showed patients with type 2 diabetes achieved glucose targets without weight gain or increasing their risk of hypoglycemia. These findings were presented at the 70th Annual Scientific Sessions of the American Diabetes Association in Orlando, Fla.
› Verified 9 days ago
Dr. Stefan S. O'connor, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2055 Limestone Rd, Suite 103, Wilmington, DE 19808 Phone: 302-992-0238 | |
Tomilade Adepoju, M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 501 W 14th St Ste 2n71, Wilmington, DE 19801 Phone: 302-320-6485 Fax: 302-320-4536 | |
Dorothy M Moore, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2055 Limestone Rd, Ste 102, Wilmington, DE 19808 Phone: 302-992-0430 Fax: 302-992-0461 | |
Temidayo Adekoyejo Olurin, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1403 N Rodney St, Wilmington, DE 19806 Phone: 302-654-4800 Fax: 302-984-0440 | |
Dr. Dorothy H. Hendricks, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 1600 Rockland Rd, Alfred I. Dupont Hospital For Children, Wilmington, DE 19803 Phone: 302-651-4000 Fax: 302-651-4945 | |
Dr. Jonathan H. Salvin, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: A.i. Dupont Hospital For Children, 1600 Rockland Road, Wilmington, DE 19803 Phone: 302-651-4000 Fax: 302-651-4945 | |
Tabassum Ali, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3501 Silverside Rd, Wilmington, DE 19810 Phone: 302-479-3937 |